Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia

Platelets

Volumn 19, Issue 3, 2008, Pages 192-198

  Nomura, Shosaku ^a   Inami, Norihito ^b   Ozaki, Yoshio ^b   Kagawa, Hideo ^b   Fukuhara, Shirou ^b  

^a Kishiwada City Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Fibroblasts; Interstitial pneumonia; Microparticles; Monocyte derived; Platelet derived microparticles; Progressive systemic sclerosis

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; BIOLOGICAL MARKER; CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTERSTITIAL PNEUMONIA; LYMPHOCYTE ACTIVATION; MALE; MONOCYTE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC SCLEROSIS;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL ADHESION MOLECULES; CELL LINE; CYTOKINES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MONOCYTES; PLATELET ACTIVATION; SCLERODERMA, DIFFUSE; THROMBOPLASTIN;

EID: 42449164330     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701882038     Document Type: Article

References (41)

1. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004;140:37-50.
2. Harrison NK, Myers R, Corrin B, Soosay G, Dewar A, Black CM, Du Bois RM, Turner-Warwick M. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144:706-713.
3. Keane MP, Belperio JA, Burdick MD, Lynch JP III, Fishbein MC, Strieter RM. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respr Crit Care Med 2001;164:2239-2242.
4. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fbroblasts. Clin Exp Immunol 2006;144:494-502.
5. Nagahama M, Nomura S, Ozaki Y, Yoshimura C, Kagawa H, Fukuhara S. Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity 2001;33:85-94.
6. Lippi G, Volpe A, Caramaschi P, Salvagno GL, Montagnana M, Guidi GC. Plasma D-dimer concentration in patients with systemic sclerosis. Thromb J 2006;4:2-4.
7. Power CA, Furness RB, Brawand C, Wells TN. Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets. Gene 1994;151:333-334.
8. Kameyoshi Y, Dorschner A, Mallet AI, Christphers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992;176:587-592.
9. Kanazawa S, Yamaguchi K, Kinoshita Y, Komiyama Y, Muramatsu M, Nomura S. Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib. J Cancer Res Clin Oncol 2006;132:719-725.
10. Inami N, Nomura S, Manabe K, Kimura Y, Iwasaka T. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris. Platelets 2006;17:565-570.
11. Okada N, Fukunaga K, Takano Y, Dogru M, Tsubota K, Fujishima H, Matsumoto K, Nakajima T, Saito H. The implications of the upregulation of ICAM-1/VCAM-1 expression of corneal fibroblasts on the pathogenesis of allergic keratopathy. Invest Ophthalmol Vis Sci 2005;46:4512-4518.
12. Waters CE, Shi-Wen X, Denton CP, Abraham DJ, Pearson JD. Signaling pathways regulating intercellular adhesion molecule 1 expression by endothelin 1: Comparison with interleukin 1β in normal and scleroderma dermal fibroblasts. Arthritis Rheum 2006;54:649-660.
13. Vancheri C, Mastruzzo C, Tomaselli V, Sortino MA, D'Amico L, Bellistri G, Pistorio MP, Salinaro ET, Palermo F, Mistretta A, et al. Normal human lung fibroblasts differently modulate interleukin-10 and interleukin-12 production by monocytes: Implications for an altered immune response in pulmonary chronic inflammation. Am J Respr Cell Mol Biol 2001;25:592-599.
14. Satta N, Toti F, Feugeas O, Bohbot A, Dachery-Prigent J, Eschwege V, Hedman H, Frevssinet JM. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994;153:3245-3255.
15. Robinson RA, Worfolk L, Tracy PB. Endotoxin enhances the expression of monocyte prithrombinase activity. Blood 1992;79:406-416.
16. Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996;88:3456-3464.
17. Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001;74:397-404.
18. Nomura S, Inami N, Iwasaka T, Liu Y. Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: Therapeutic effects by cilostazol and potentiation by dipyridamole. Platelets 2004;15:167-172.
19. Nomura S, Inami N, Kimura Y, Omoto S, Shouzu A, Nishikawa M, Iwasaka T. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens 2007;21:38-44.
20. Omoto S, Nomura S, Shouzu A, Nishikawa M, Fukuhara S, Iwasaka T. Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetlogia 2002;45:550-555.
21. Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T, Fukuhara S. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: Clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin Appl Thromb Hemost 2004;10:205-215.
22. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S, Iwasaka T. Effect of valsartan on monocyte/endothelial cell activation maekers and adiponectin in hypertensive patients with type 2 diabetes mellitus. Thromb Res 2006;117:385-392.
23. Cerri C, Chimenti D, Conti I, Neri T, Paggiaro P, Celi A. Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells. J Immunol 2006;177:1975-1980.
24. Osumi K, Ozeki Y, Saito S, Nagamura Y, Ito H, Kimura Y, Ogura H, Nomura S. Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 2001;85:326-330.
25. Horsewood P, Hayward CP, Warkentin TE, et al. Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood 1991;78:1019-1026.
26. Sobocka MB, Sobocki T, Banerjee P, et al. Cloning of the human platelet F11 receptor: A cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood 2000;95:2600-2609.
27. Kiraz S, Ertenli I, Benekli M, Haznedaroglu IC, Calguneri M, Celik I. Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: Evidence for a prothrombotic state. Lupus 1999;8:737-741.
28. Boehme MW, Raeth U, Galle PR, Stremmel W, Scherbaum WA. Serum thrombomodulin - a reliable marker of disease activity in sysyemic lupus erythematosus (SLE): Advantage over established serological parameters to indicate disease activity. Clin Exp Immunol 2000;119:189-195.
29. Cerinic MM, Valentini G, Sorano GG, D'Angelo S, Cuomo G, Fenu L, Generini S, Cinotti S, Morfini M, Piqnone A, et al. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthtitis Rheum 2003;32:285-295.
30. Kahaleh MB. Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004;223(Suppl 33):S19-S23.
31. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988;263:18205-18212.
32. Nomura S, Suzuki M, Katsura K, Xie GL, Mayazaki Y, Miyake T, Kido H, Kagawa H, Fukuhara S. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes. Atherosclerosis 1995;116:235-240.
33. Nomura S, Takahashi N, Inami N, Kajiura T, Yamada K, Nakamori H, Tsuda N. Probucol and ticlopidine: Effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis 2004;174:329-335.
34. Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely surface expressed on lipopolysaccharide stimulated human blood monocytes and a constitutively tissue factor producing neoplastic cell line. J Cell Biol 1989;109:389-394.
35. Osnes LTN, Westvik AB, Kieruf P. Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb Res 1994;76:373-383.
36. Agostini C, Siviero M, Semenzato G. Immune effector cells in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 1997;3:48-55.
37. Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment. Clin Immunol 2001;99:308-319.
38. Crowston JG, Salmon M, Khaw PT, Akbar AN. T-lymphocyte-fibroblast interactions. Biochem Soc Trans 1997;25:529-531.
39. Hogaboam CM, Smith RE, Kunkel SL. Dynamic interations between lung fibrablasts and leukocytes: Implications for fibrotic lung disease. Proc Assoc Am Physicians 1998;110:313-320.
40. Sempowski GD, Chess PR, Phipps RP. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 1997;158:4670-4677.
41. De L, Karison T, Whiting CV, Bland PW. Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-γ- mediated upregulation of CD40 signalling. Clin Exp Immunol 2007;147:313-323.